Close Menu

NEW YORK (GenomeWeb News) – The Baylor College of Medicine's Medical Genetics Laboratories will use Illumina's Infinium High-Density DNA Analysis products in genomic studies of developmental disorders.

Specifically, the Houston-based lab intends to use Illumina's arrays for studying genomic imprinting and its role in developmental diseases such as Prader-Willi syndrome, Angelman syndrome, and other disorders caused by uniparental disomy.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK and the European Union have come to a sticking point in the negotiation of how the UK might remain involved in the Horizon Europe research program, the Guardian reports.

The New York Times reports that experts pushed during a meeting of an FDA advisory board for the agency to require more safety data from SARS-CoV-2 vaccine trials.

The Washington Post reports Moderna expects that it will have enough data on its candidate SARS-CoV-2 vaccine to submit to regulatory authorities by mid-November.

In Science this week: ANXA11 variants affect calcium homeostasis and stress granule disassembly in ALS, and more.

Nov
11
Sponsored by
Illumina

Selective breeding represents an efficient approach to increase production of aquaculture species by means of improving traits, such as rapid growth, product quality, and disease resistance.